Patent details

Basic Information

Publication number:

EP3075386

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP161536941

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FORMULATIONS FOR LYSOSOMAL ENZYMES

French Title of Invention:

FORMULATIONS POUR ENZYMES LYSOSOMALES

German Title of Invention:

FORMULIERUNGEN FÜR LYSOSOMALE ENZYME

SPC Number:

Dates

Filing date:

17/06/2010

Grant date:

16/10/2019

EP Publication Date:

05/10/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/10/2019

EP B1 Publication Date:

16/10/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/06/2020

Expiration date:

17/06/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

09/10/2019

 

 

Name:

BioMarin Pharmaceutical Inc.

Address:

105 Digital Drive, Novato, CA 94949, United States (US)

Inventor

1

Name:

CHANG, Byeong

Address:

United States (US)

2

Name:

LEBOWITZ, Jonathan

Address:

United States (US)

Priority

Priority Number:

187747 P

Priority Date:

17/06/2009

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/16; A61K 38/17; A61K 38/46; A61K 47/30; A61P 3/00; A61K 47/34;

Publication

European Patent Bulletin

1

Issue number:

201942

Publication date:

16/10/2019

Description:

Grant (B1)

2

Issue number:

201947

Publication date:

20/11/2019

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages